The University of Arizona Health Sciences this month will feature the work of its Comprehensive Pain and Addiction Center as part of National Cannabis Awareness Month.

Federal officials threw a lifeline this week to as many as 500,000 Arizonans, days before they were about to lose the Medicaid coverage received under the COVID-19 public health emergency.

The Arizona Department of Health Services has stopped reporting some information on COVID-19 hospitalizations but data that is still available suggests Arizona’s outbreak is continuing to improve.

Overdose deaths in adolescents nearly doubled in 2020 from the year before and increased substantially in 2021 after nearly a decade of fairly stable rates, according to data published in a JAMA research letter. A Health Sciences assistant professor is quoted.

The second COVID-19 booster shot is available for those who are 50 or older or have underlying health problems, but many are left wondering if they should get it.

The Valley Fever Collaborative, a University of Arizona Health Sciences-led partnership with Arizona State University and Northern Arizona University, was awarded $3.1 million in Regents’ Grant funding by the Arizona Board of Regents to start an integrated, statewide research project to identify, characterize and map hotspots and routes of exposure for Valley fever.

Researchers in the Comprehensive Pain and Addiction Center are seeking new therapies for migraine in an unlikely place – the endogenous cannabinoid system.

The Arizona Board of Regents voted to confirm the appointments of University of Arizona Health Sciences faculty members Drs. Juanita Merchant and Donata Vercelli as Regents Professors.

The Arizona Board of Regents is putting $4.5 million toward Valley fever research over the next three years.